The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach

Y. Yazdanpanah, M. Vray, J. Meynard, E. Losina, M.C. Weinstein, L. Morand-Joubert (), S.J. Goldie, H.E. Hsu, R.P. Walensky, C. Dalban, P.E. Sax, P.M. Girard and K.A. Freedberg
Additional contact information
Y. Yazdanpanah: LEM - Lille - Economie et Management - Université de Lille, Sciences et Technologies - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2007
References: Add references at CitEc
Citations:

Published in HIV Medicine, 2007, 8 ((7)), pp.439-450

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-00281669

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().